Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interaction between caffeine consumption & genetic susceptibility in Parkinson's disease: A systematic review. | Ageing Res Rev | 2024 | 38914264 | PubTator, text mining | PubMed |
| Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol. | medRxiv | 2024 | 38853861 | PubTator, text mining | PubMed |
| A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data. | Clin Transl Sci | 2024 | 38853370 | PubTator, text mining | PubMed |
| LINC00520 promotes colorectal cancer progression through miRNA-195-3p / NAT2 axis. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38836661 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Drug Utilization Patterns, Gender Disparities, Lifestyle Influences, and Genetic Factors: Insights from Elderly Cohort Using g-Nomic® Software. | Pharmaceuticals (Basel) | 2024 | 38794134 | PubTator, text mining | PubMed |
| Corrected speciation and gyromitrin content of false morels linked to ALS patients with mostly slow-acetylator phenotypes. | eNeurologicalSci | 2024 | 38770222 | PubTator, text mining | PubMed |
| Function and expression of N-acetyltransferases 1 and 2 are altered in lymphocytes in type 2 diabetes and obesity. | Biochem Biophys Rep | 2024 | 38737726 | PubTator, text mining | PubMed |
| Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants. | Genes (Basel) | 2024 | 38674455 | PubTator, text mining | PubMed |
| Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations. | Pharmacol Res Perspect | 2024 | 38666760 | PubTator, text mining | PubMed |
| Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection. | J Antimicrob Chemother | 2024 | 38661209 | PubTator, text mining | PubMed |
| Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling. | AAPS J | 2024 | 38658473 | PubTator, text mining | PubMed |
| Cascading Detection of Hydrogen Sulfide and N-Acetyltransferase 2 in Hepatocellular Carcinoma Cells Using a Two-Photon Fluorescent Probe. | Anal Chem | 2024 | 38657082 | PubTator, text mining | PubMed |
| Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. | Clin Transl Sci | 2024 | 38629592 | PubTator, text mining | PubMed |
| ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation. | BMC Cancer | 2024 | 38605349 | PubTator, text mining | PubMed |
| Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships. | Front Pharmacol | 2024 | 38584604 | PubTator, text mining | PubMed |
| High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. | Am J Respir Crit Care Med | 2024 | 38564365 | PubTator, text mining | PubMed |
| Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model Repository. | Drug Des Devel Ther | 2024 | 38500691 | PubTator, text mining | PubMed |
| Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity. | Exp Mol Med | 2024 | 38424191 | PubTator, text mining | PubMed |
| The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction. | Pharmacol Rev | 2024 | 38351074 | PubTator, text mining | PubMed |
| Pharmacogenetic Analysis of an 8-Year Old Girl with Reye Syndrome Associated with Use of Naproxen. | Am J Case Rep | 2024 | 38311849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=8